Bio-Techne Corp at Leerink Partners Global Healthcare Conference Transcript
So glad to have everyone here. Let's get started. So it's my pleasure to host Bio-Techne's CEO, Chuck Kummeth; and CFO, Jim Hippel. Great to have you guys here.
I'm Puneet Souda, SVB Leerink Tools and Diagnostic Analyst. So maybe first -- we have a different format this year. So let's get -- jump into couple of slides, and then we can jump to questions after that.
Okay. Looks like it's on. I'll rip through these quick, a little bit -- it's a primer on our company.
So we're roughly $7 billion or so market cap. We've grown from 700 people to 2,100 in the last 5, 6 years.
You can see our fiscal 2008 revenues there. You can see our breakup. This 65% is kind of the original portions of the company. It's a 42-year-old company, but most of me and my team have been around 5, 6 years, so we're more like a 5-year-old company really.
And we've
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
